Human Stem Cells Institute OJSC engages in R&D and marketing of cell-based, gene and post-genome products and services. The Company markets a cord blood stem cell bank, a gene-therapy drug for treating PAD, and a cell technology to repair skin damage due to aging. Human Stem Cells also offers genetic diagnostics and consulting services for inherited disorders.
3 Gubkina Street
PO Box 373, Building 2